# AskGene Pharma

Source: https://onco.cc/companies/askgene-pharma/  
OnCo record `askgene-pharma` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

AskGene Pharma is a United States-based biotechnology company running 2 late-stage cancer trials of ASKG915 and Fruquintinib in gastric & gastro-oesophageal junction cancer.

## Summary

AskGene Pharma, based in Camarillo, the United States, is a biotechnology company. AskGene Pharma develops cytokine prodrug therapeutics using its SmartKine platform technology, targeting oncology and autoimmune disease indications. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing ASKG915 and Fruquintinib in gastric & gastro-oesophageal junction cancer. The largest, NCT05867420 (A Study of ASKG915 in Patients With Selected Advanced Solid Tumours), plans to enrol 594 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Also known as: AskGene Pharma, Inc.
- Tags: ctgov-sponsor
- HQ: Camarillo
- Type: biotech
- Website: https://www.ask-gene.com

## Sources

- Official website: https://www.ask-gene.com
- ClinicalTrials.gov: trials led by AskGene Pharma: https://clinicaltrials.gov/search?lead=AskGene%20Pharma%2C%20Inc.

## Connected records

- cancers: [Gastric & gastro-oesophageal junction cancer](https://onco.cc/cancers/gastric/)
- drugs: [Fruquintinib](https://onco.cc/drugs/fruquintinib/)
- trials: [A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.](https://onco.cc/trials/nct05867420/), [ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer.](https://onco.cc/trials/nct05632939/)

---
JSON: https://onco.cc/api/v1/entities/askgene-pharma.json